1 |
Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress in adults [J]. Lancet, 1967, 2(7511): 319-323.
|
2 |
Bernard GR, Artigas A, Brigham KL, et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee [J]. Intensive Care Med, 1994, 20(3): 225-232.
|
3 |
Force ADT, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition [J]. JAMA, 2012, 307(23): 2526-2533.
|
4 |
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries [J]. JAMA, 2016, 315(8): 788-800.
|
5 |
Huppert LA, Matthay MA, Ware LB. Pathogenesis of acute respiratory distress syndrome [J]. Semin Respir Crit Care Med, 2019, 40(1): 31-39.
|
6 |
Thille AW, Esteban A, Fernandez-Segoviano P, et al. Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy [J]. Am J Respir Crit Care Med, 2013, 187(7): 761-767.
|
7 |
Jabaudon M, Futier E, Roszyk L, et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients [J]. Crit Care Med, 2011, 39(3): 480-488.
|
8 |
Jones TK, Feng R, Kerchberger VE, et al. Plasma sRAGE acts as a genetically regulated causal intermediate in sepsis-associated acute respiratory distress syndrome [J]. Am J Respir Crit Care Med, 2020, 201(1): 47-56.
|
9 |
Terpstra ML, Aman J, Van Nieuw Amerongen GP, et al. Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis [J]. Crit Care Med, 2014, 42(3): 691-700.
|
10 |
Van Der Heijden M, Van Nieuw Amerongen GP, Koolwijk P, et al. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients [J]. Thorax, 2008, 63(10): 903-909.
|
11 |
Agrawal A, Matthay MA, Kangelaris KN, et al. Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients [J]. Am J Respir Crit Care Med, 2013, 187(7): 736-742.
|
12 |
Huber W, Findeisen M, Lahmer T, et al. Prediction of outcome in patients with ARDS: A prospective cohort study comparing ARDS-definitions and other ARDS-associated parameters, ratios and scores at intubation and over time [J]. PLoS One, 2020, 15(5): e0232720.
|
13 |
Tagami T, Ong MEH. Extravascular lung water measurements in acute respiratory distress syndrome: why, how, and when? [J]. Curr Opin Crit Care, 2018, 24(3): 209-215.
|
14 |
Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? [J]. Intensive Care Med, 2020, 46(6): 1099-1102.
|
15 |
Panwar R, Madotto F, Laffey JG, et al. Compliance phenotypes in early acute respiratory distress syndrome before the COVID-19 Pandemic [J]. Am J Respir Crit Care Med, 2020, 202(9): 1244-1252.
|
16 |
Xie X, Zhong Z, Zhao W, et al. Chest CT for typical coronavirus disease 2019 (COVID-19) pneumonia: relationship to negative RT-PCR testing [J]. Radiology, 2020, 296(2): E41-E45.
|
17 |
Ye Z, Zhang Y, Wang Y, et al. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review [J]. Eur Radiol, 2020, 30(8): 4381-4389.
|
18 |
Menter T, Haslbauer JD, Nienhold R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction [J]. Histopathology, 2020, 77(2): 198-209.
|
19 |
Hanley B, Naresh KN, Roufosse C, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study [J]. Lancet Microbe, 2020, 1(6): e245-e253.
|
20 |
Bradley BT, Maioli H, Johnston R, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series [J]. Lancet, 2020, 396(10247): 320-332.
|
21 |
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J]. Lancet, 2020, 395(10223): 497-506.
|
22 |
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [J]. JAMA, 2020, 323(11): 1061-1069.
|
23 |
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [J]. Lancet, 2020, 395(10229): 1054-1062.
|
24 |
Matthay MA, Thompson BT, Ware LB. The Berlin definition of acute respiratory distress syndrome: should patients receiving high-flow nasal oxygen be included? [J]. Lancet Respir Med, 2021, 9(8): 933-936.
|
25 |
Pham T, Pesenti A, Bellani G, et al. Outcome of acute hypoxaemic respiratory failure: insights from the LUNG SAFE Study [J]. Eur Respir J, 2021, 57(6).
|
26 |
Rice TW, Wheeler AP, Bernard GR, et al. Comparison of the SpO2/FiO2 ratio and the PaO2/FiO2 ratio in patients with acute lung injury or ARDS [J]. Chest, 2007, 132(2): 410-417.
|
27 |
Sanz F, Dean N, Dickerson J, et al. Accuracy of PaO2 /FiO2 calculated from SpO2 for severity assessment in ED patients with pneumonia [J]. Respirology, 2015, 20(5): 813-818.
|
28 |
Chen W, Janz DR, Shaver CM, et al. Clinical characteristics and outcomes are similar in ARDS diagnosed by oxygen saturation/FiO2 ratio compared with PaO2/FiO2 ratio [J]. Chest, 2015, 148(6): 1477-1483.
|
29 |
Riviello ED, Kiviri W, Twagirumugabe T, et al. Hospital incidence and outcomes of the acute respiratory distress syndrome using the Kigali modification of the Berlin definition [J]. Am J Respir Crit Care Med, 2016, 193(1): 52-59.
|
30 |
Riviello ED, Buregeya E, Twagirumugabe T. Diagnosing acute respiratory distress syndrome in resource limited settings: the Kigali modification of the Berlin definition [J]. Curr Opin Crit Care, 2017, 23(1): 18-23.
|
31 |
Ranieri VM, Tonetti T, Navalesi P, et al. High-flow nasal oxygen for severe hypoxemia: oxygenation response and outcome in patients with COVID-19 [J]. Am J Respir Crit Care Med, 2022, 205(4): 431-439.
|